News & Updates
Filter by Specialty:
Lower resilience tied to poorer medication adherence in glaucoma patients
The COVID-19 pandemic has worsened the adherence to ocular hypotensive medication among patients with primary open-angle glaucoma (POAG), according to a study. Such reduction is potentially driven by lower psychometric measures of resilience and more confrontational coping strategies.
Lower resilience tied to poorer medication adherence in glaucoma patients
18 Mar 2022
Over-the-counter nutritional supplement may help avert gestational diabetes
Myo-inositol, a nutritional supplement that is present in fruits and fibre-rich foods, shows promise in the prevention of gestational diabetes, as reported in a study.
Over-the-counter nutritional supplement may help avert gestational diabetes
18 Mar 2022
Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction
Receipt of a booster dose of the COVID-19 vaccine reduces the risk of breakthrough COVID-19 infections* compared to full vaccination only, particularly among individuals without immunosuppressed/compromised conditions (ISC), according to a US study presented at CROI 2022.
Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction
17 Mar 2022
Ocular biometrics help predict progression of primary angle closure disease
Use of ocular biometric measurements can stratify patients with early angle closure at risk for more severe disease, according to a study.
Ocular biometrics help predict progression of primary angle closure disease
17 Mar 2022
DOAC use persists in NVAF patients with liver disease
A knowledge gap exists on the effects of direct oral anticoagulants (DOACs), but most nonvalvular atrial fibrillation (NVAF) patients with liver disease still begin treatment with these medications, particularly apixaban and rivaroxaban, a study has found.